Sphingolipids in human ileostomy content after meals containing milk sphingomyelin

American Journal of Clinical Nutrition

Volumn 91, Issue 3, 2010, Pages 672-678

  Ohlsson, Lena ^a   Hertervig, Erik ^b   Jönsson, Bo A G ^b   Duan, Rui Dong ^a   Nyberg, Lena ^c   Svernlöv, Rikard ^b   Nilsson, Åke ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Swedish Dairy Association   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; LONG CHAIN FATTY ACID; PALMITOYLCERAMIDE; PALMITOYLSPHINGOMYELIN; SPHINGOLIPID; SPHINGOSINE; STEAROYLCERAMIDE; STEAROYLSPHINGOMYELIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOOD COMPOSITION; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; ILEOSTOMY; MALE; METABOLITE; MILK; POSTPRANDIAL STATE; TEST MEAL;

ADULT; ANIMALS; CERAMIDES; COLON; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; FEMALE; HUMANS; ILEOSTOMY; MALE; MIDDLE AGED; MILK; SPHINGOMYELINS; YOUNG ADULT;

EID: 77749279629     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.28311     Document Type: Article

References (30)

1. Nilsson A, Duan RD. Absorption and lipoprotein transport of sphingomyelin. J Lipid Res 2006;47:154-71.
2. Duan RD. Alkaline sphingomyelinase: an old enzyme with novel implications. Biochim Biophys Acta 2006;1761:281-91.
3. Kobayashi T, Suzuki K. The glycosylceramidase in the murine intestine. Purification and substrate specificity. J Biol Chem 1981;256:7768-73.
4. Duan RD, Cheng Y, Yang L, Ohlsson L, Nilsson A. Evidence for specific ceramidase present in the intestinal contents of rats and humans. Lipids 2001;36:807-12.
5. Nilsson Å. Metabolism of sphingomyelin in the intestinal tract of the rat. Biochim Biophys Acta 1968;164:575-84.
6. Sugawara T, Kinoshita M, Ohnishi M, Nagata J, Saito M. Digestion of maize sphingolipids in rats and uptake of sphingadienine by Caco-2 cells. J Nutr 2003;133:2777-82.
7. Garmy N, Taieb N, Yahi N, Fantini J. Apical uptake and transepithelial transport of sphingosine monomers through intact human intestinal epithelial cells: physicochemical and molecular modeling studies. Arch Biochem Biophys 2005;440:91-100.
8. Nyberg L, Nilsson Å, Lundgren P, Duan R-D. Localization and capacity of sphingomyelin digestion in the rat intestinal tract. J Nutr Biochem 1997;8:112-8.
9. Nyberg L, Duan RD, Nilsson Å. A mutual inhibitory effect on absorption of sphingomyelin and cholesterol. J Nutr Biochem 2000;11:244-9.
10. Schmelz EM, Roberts PC, Kustin EM, et al. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids. Cancer Res 2001;61:6723-9.
11. Schmelz EM, Dillehay DL,Webb SK, Reiter A, Adams J, Merrill AH Jr. Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res 1996;56:4936-41.
12. Duan RD, Bergman T, Xu N, et al. Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family. J Biol Chem 2003;278: 38528-36.
13. Ohlsson L, Palmberg C, Duan RD, Olsson M, Bergman T, Nilsson A. Purification and characterization of human intestinal neutral ceramidase. Biochimie 2007;89:950-60.
14. Duan RD, Nilsson Å. Purification of a newly identified alkaline sphingomyelinase in human bile and effects of bile salts and phosphatidylcholine on enzyme activity. Hepatology 1997;26:823-30.
15. Vesper H, Schmelz EM, Nikolova-Karakashian MN, Dillehay DL, Lynch DV, Merrill AH Jr. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J Nutr 1999;129:1239-50.
16. Nilsson A. Sphingolipids. In: Gunstone FD, ed. Phospholipid technology and applications. Bridgewater, United Kingdom: The Oily Press, 2008: 169-94
17. Nyberg L, Duan RD, Axelsson J, Nilsson Å. Identification of an alkaline sphingomyelinase activity in human bile. Biochim Biophys Acta 1996; 1300:42-8.
18. Duan RD, Cheng Y, Jonsson BA, et al. Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites. Pediatr Res 2007;61:61-6.
19. Byrdwell WC, Perry RH. Liquid chromatography with dual parallel mass spectrometry and 31P nuclear magnetic resonance spectroscopy for analysis of sphingomyelin and dihydrosphingomyelin. II. Bovine milk sphingolipids. J Chromatogr A 2007;1146:164-85.
20. Grieve AP. Tests of sphericity of normal distributions and the analysis of repeated measures designs. Psychometrika 1984;49:257-67.
21. Duan RD, Hertervig E, Nyberg L, et al. Distribution of alkaline sphingomyelinase activity in human beings and animals. Tissue and species differences. Dig Dis Sci 1996;41:1801-6.
22. Breimer ME. Distribution of molecular species of sphingomyelins in different parts of bovine digestive tract. J Lipid Res 1975;16:189-94.
23. Bouhours J-F, Guignard H. Free ceramide, sphingomyelin, and glucosylceramide of isolated rat intestinal cells. J Lipid Res 1979;20: 879-907.
24. Nibbering CP, Carey MC. Sphingomyelins of rat liver: biliary enrichment with molecular species containing 16:0 fatty acids as compared to canalicular-enriched plasma membranes. J Membr Biol 1999;167: 165-71.
25. Liu J-J, Nilsson Å, Duan R-D. In vitro effects of fat, fatty acids, and cholesterol on sphingomyelin hydrolysis induced by rat intestinal alkaline sphingomyelinase. Lipids 2002;37:469-74.
26. Garmy N, Taieb N, Yahi N, Fantini J. Interaction of cholesterol with sphingosine: physicochemical characterization and impact on intestinal absorption. J Lipid Res 2005;46:36-45.
27. Simon KW, Roberts PC, Vespremi MJ, Manchen S, Schmelz EM. Regulation of beta-catenin and connexin-43 expression: targets for sphingolipids in colon cancer prevention. Mol Nutr Food Res 2009;53: 332-40.
28. Zhang P, Li B, Gao S, Duan RD. Dietary sphingomyelin inhibits colonic tumorigenesis with an up-regulation of alkaline sphingomyelinase expression in ICR mice. Anticancer Res 2008;28:3631-5.
29. Lemonnier LA, Dillehay DL, Vespremi MJ, Abrams J, Brody E, Schmelz EM. Sphingomyelin in the suppression of colon tumors: prevention versus intervention. Arch Biochem Biophys 2003;419: 129-38.
30. Duivenvoorden I, Voshol PJ, Rensen PC, et al. Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3 Leiden mice. Am J Clin Nutr 2006;84:312-21.